Intestinal dysbiosis featuring abundance of Streptococcus associates with Henoch-Schönlein purpura nephritis (IgA vasculitis with nephritis) in adultOriginal paper
What was studied?
This study investigated whether gut microbiota dysbiosis associates with Henoch-Schonlein purpura nephritis, also called IgA vasculitis with nephritis, in adults. Fecal bacteria were profiled by 16S ribosomal RNA gene sequencing of the V3-V4 region on the Illumina MiSeq platform, analyzed at genus level. Diversity, community structure, and differential taxa were compared between patients and controls. A receiver operating characteristic model assessed diagnostic value, and genera were correlated with clinical indices.
Who was studied?
The study enrolled 52 adults at West China Hospital, Sichuan University, in Chengdu, China, between June 2018 and November 2019. It compared 26 patients with clinically and pathologically diagnosed Henoch-Schonlein purpura nephritis against 26 healthy controls matched for sex and age. Samples were collected at diagnosis before immunosuppressive therapy, with a unified diet 3 days beforehand and no antibiotics within 4 weeks. Kidney-damage markers were clearly worse in patients.
What were the most important findings?
Patients showed lower gut diversity, with ace index 288.06 and chao index 294.71 versus 366.04 and 371.36 in controls. Three genera were increased in patients: Bacteroides (p = 0.016), Escherichia-Shigella (p = 0.021), and Streptococcus (p = 0.012), while Prevotella_9 was reduced (p = 0.016). A four-genus classifier reached an area under the curve of 0.86. Streptococcus correlated positively with urinary red blood cells (r = 0.492, p = 0.011) and negatively with serum albumin (r = -0.474, p = 0.014).
What are the greatest implications of this study?
The results suggest adult Henoch-Schonlein purpura nephritis features gut dysbiosis marked by fewer beneficial bacteria and more potential pathogens. Higher Streptococcus tracked with hematuria, hypoalbuminemia, and severe pathology, and correlated with abnormal Gd-IgA1-to-IgA ratios, hinting at a role in disease severity through mucosal immunity. The authors propose fecal bacteria as a possible diagnostic aid and microbiome modulation as a therapeutic direction. As a cross-sectional observational study, it cannot establish that dysbiosis causes or drives the disease.